You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ITP；glycyrrhetinic acid；dexamethasone

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Thrombocytopenia Trial in Jinan (Caffeic acid tablets, Dexamethasone, )

Completed
  • Immune Thrombocytopenia
  • Caffeic acid tablets
  • +2 more
  • Jinan, Shandong, China
    Qilu Hospital, Shandong University
Mar 19, 2020

Primary Immune Thrombocytopenia (ITP) Trial in Switzerland (Eltrombopag (Revolade®), standard therapy (without eltrombopag):

Recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • Eltrombopag (Revolade®)
  • standard therapy (without eltrombopag): HD-DXM
  • Aarau, Switzerland
  • +5 more
Sep 5, 2022

Immune Thrombocytopenia Trial in Beijing (Dexamethasone, ATRA)

Completed
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Sep 22, 2021

Immune Thrombocytopenia Trial in Bristol (Mycophenolate Mofetil, Prednisolone)

Completed
  • Immune Thrombocytopenia
  • Bristol, United Kingdom
    University Hospital Bristol NHS Foundation Trust
Oct 25, 2022

Immune Thrombocytopenia Trial in Beijing (Baricitinib 2 MG, Dexamethasone)

Recruiting
  • Immune Thrombocytopenia
  • Beijing, China
  • +9 more
Jul 11, 2023

Immune Thrombocytopenia Trial in Jinan, Qingdao (dexamethasone, diammonium glycyrrhizinate enteric-coated capsule)

Recruiting
  • Immune Thrombocytopenia
  • Jinan, Shandong, China
  • +1 more
Aug 21, 2021

ITP - Immune Thrombocytopenia Trial (hetrombopag 5mg po qd, High-dose Dexamethasone)

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • hetrombopag 5mg po qd
  • High-dose Dexamethasone
  • (no location specified)
Jul 5, 2023

Immune Thrombocytopenia (ITP) Trial in Germany (Eltrombopag, Dexamethasone)

Recruiting
  • Immune Thrombocytopenia (ITP)
  • Mannheim, Baden-Wuerttemberg, Germany
  • +24 more
Dec 19, 2022

Immune Thrombocytopenia Trial (Zanubrutinib, Dexamethasone)

Not yet recruiting
  • Immune Thrombocytopenia
  • (no location specified)
May 6, 2022

Immune Thrombocytopenia Trial in Hong Kong (Eltrombopag)

Suspended
  • Immune Thrombocytopenia
  • Hong Kong, Hong Kong SAR, Hong Kong
    Humanity & Health Research Centre
Mar 16, 2022

Pediatric Primary Immune Thrombocytopenia (ITP)

Recruiting
  • Primary Immune Thrombocytopenia
  • data collection
  • Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Oct 31, 2023

Thrombocytopenia Trial (Chidamide, HD-DXM)

Not yet recruiting
  • Thrombocytopenia
  • (no location specified)
Jun 6, 2022

Recurrent Plasma Cell Myeloma Trial in Jacksonville (Dexamethasone, Laboratory Biomarker Analysis, Lenalidomide)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 4, 2023

Low Back Pain Trial in Germany, Italy (ITP FIRTECH, No Patch)

Completed
  • Low Back Pain
  • ITP FIRTECH
  • Bad Homburg, Germany
  • +6 more
Dec 15, 2022

Antiphospholipid Antibodies and Microparticles in Immune

Not yet recruiting
  • Thrombosis
  • Antiphospholipid antibodies
  • (no location specified)
Apr 25, 2023

Multiple Sclerosis Trial in Los Angeles (Blood draw for future biomarker analysis)

Completed
Has Results
  • Multiple Sclerosis
  • Blood draw for future biomarker analysis
  • Los Angeles, California
    Investigational Site Number 8400001
Mar 15, 2022

Periodontal Surgery Trial in Kaohsiung (Enoxolone, Sensodyne)

Completed
  • Periodontal Surgery
  • Enoxolone
  • Sensodyne
  • Kaohsiung, Taiwan
    Kaohsiung Medical University Hospital, Kaohsiung Medical Univers
Aug 4, 2023

Immune Thrombocytopenia (ITP) Trial (Neofordex®, Intravenous immunoglobulins)

Not yet recruiting
  • Immune Thrombocytopenia (ITP)
  • (no location specified)
Nov 22, 2021

Course of COVID-19 in Prior, Ongoing or de Novo ITP. Evaluation

Recruiting
  • Immune Thrombocytopenia
  • +3 more
    • Brescia, Italy
    • +7 more
    Aug 24, 2022

    Primary Immune Thrombocytopenia Trial in Worldwide (PF-06835375)

    Suspended
    • Primary Immune Thrombocytopenia
    • PF-06835375
    • Jacksonville, Florida
    • +27 more
    Jan 25, 2023

    Immune Thrombocytopenia Trial (VIT D)

    Not yet recruiting
    • Immune Thrombocytopenia
    • VIT D
    • (no location specified)
    Oct 5, 2023

    Primary Immune Thrombocytopenia (ITP) Trial in Tianjin (TPO-RAs, TPO-RAs combining anti-CD 20 mAb)

    Not yet recruiting
    • Primary Immune Thrombocytopenia (ITP)
    • TPO-RAs
    • TPO-RAs combining anti-CD 20 monoclonal antibody
    • Tianjin, China
      Institute of Hematology and Blood Diseases Hospital, Chinese Aca
    Feb 7, 2023

    Idiopathic Thrombocytopenic Purpura Trial in Worldwide (Romiplostim)

    Completed
    Has Results
    • Idiopathic Thrombocytopenic Purpura
    • Romiplostim
    • Anaheim, California
    • +47 more
    Sep 8, 2022

    Primary Immune Thrombocytopenia Trial in Shandong (QL0911, Placebo comparator)

    Completed
    • Primary Immune Thrombocytopenia
    • Shandong, China
      Qilu Hospital of Shandong University
    Nov 20, 2022

    Multiple Myeloma Trial in Hackensack (Daratumumab, Pomalidomide, All-trans retinoic acid)

    Recruiting
    • Multiple Myeloma
    • Hackensack, New Jersey
      John Theurer Cancer Center
    Jun 10, 2022